Groupe CRIT Logo

Groupe CRIT

International provider of human resources, airport assistance, and industrial services.

CEN | PA

Overview

Corporate Details

ISIN(s):
FR0000036675
LEI:
969500KI179R130T7Q32
Country:
France
Address:
6 RUE TOULOUSE LAUTREC, 75017 PARIS
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Groupe CRIT is a leading international service provider specializing in human resources, airport assistance, and industrial services. The company's primary business segment focuses on temporary work and recruitment, delivering flexible workforce solutions to over 38,000 client companies through a network of nearly 600 employment agencies. A key division of the group is dedicated to airport assistance, where it holds a leading market position in France and operates internationally. Groupe CRIT also provides engineering and industrial maintenance services, partnering with major industries on technical projects. This diversified model enables the company to offer comprehensive solutions in human capital management and specialized support services.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 15:32
Interim Report
Annule et remplace : Rapport Financier Semestriel 2025
French 10.0 MB
2025-09-26 17:45
Report Publication Announcement
Modalités de mise à disposition du Rapport Financier semestriel 2025
French 220.2 KB
2025-07-23 17:45
Earnings Release
CRIT : Chiffre d’affaires du 1er semestre 2025 : 1,64 Md€ (+17,5%)
French 967.6 KB
2025-07-23 17:45
Earnings Release
CRIT : 2025 first half revenue: €1.64 billion (+17.5%)
English 943.1 KB
2025-06-20 12:59
Major Shareholding Notification
Franchissements de seuils et déclaration d'intention
French 146.6 KB
2025-05-13 17:45
Report Publication Announcement
Modalités de mise à disposition des documents préparatoires à l’Assemblée Génér…
French 237.3 KB
2025-04-30 18:00
Registration Form
Mise à disposition du Document d’Enregistrement Universel 2024 incluant le Rapp…
French 212.2 KB
2025-04-29 15:21
Annual Report (ESEF)
DOCUMENT D'ENREGISTREMENT UNIVERSEL 2024 ET RFA
French 34.7 MB
2025-04-23 17:45
Earnings Release
CRIT : Chiffre d’affaires du premier trimestre 2025 : 766,1 M€ (+31,0%)
French 964.6 KB
2025-04-23 17:45
Earnings Release
CRIT : First quarter 2025 revenue: € 766.1 million (+31.0%)
English 940.0 KB
2025-04-08 10:07
Major Shareholding Notification
Franchissements de seuils
French 117.9 KB
2025-03-25 18:24
Earnings Release
Résultats annuels 2024
French 927.9 KB
2025-03-25 18:24
Earnings Release
2024 annual results
English 927.9 KB
2025-03-06 08:00
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant …
French 252.9 KB
2025-01-09 14:03
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils et déclaration d'intention
French 457.7 KB

Automate Your Workflow. Get a real-time feed of all Groupe CRIT filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Groupe CRIT via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.